Volume : 08, Issue : 08, August – 2021
Title:
28.THE CORRELATION BETWEEN HUMAN PAPILLOMA VIRUS INFECTION AND ABNORMAL CERVICAL SMEARS IN SAUDI ARABIA
Authors :
Fatimah Al-Mubarak*, Dana Al-Mishri, Fayez Al-Zahrani, Esra’a Al-Zaid, Batool Alali, Mustafa Alsaihati
Abstract :
Background: The prevalence of human papillomavirus (HPV) infection is progressively increasing. HPV is responsible for 70% of cervical cancers worldwide; moreover, cervical cancer is the fourth leading cause of death in women.
Aim: This study investigated the association between abnormal cervical smears and HPV infection in Saudi Arabian women.
Methods: An analytical, descriptive, retrospective, patient-based cross-sectional study was conducted in Dammam, Saudi Arabia, from January to February 2020. The World Health Organization questionnaire was adopted and modified to suit Saudi culture. Patient files were reviewed, and phone interviews were conducted. Data were collected from 60 participants, with a response rate of 70%.
Results: A total of 51.7% HPV-positive samples were detected, and the majority were found in women aged over 40 years, multiparas, and in those who had their first sexual encounter at age 12–23 years. There was no significant association between the use of any form of hormonal contraceptive by either the women or their partners and the risk of HPV or cervical abnormality.
Conclusion: The prevalence of HPV infection was high among the women with abnormal cervical biopsies. The end-result of cervical cancer emphasizes the importance of national screening programs and inclusion of the HPV vaccine in the national immunization program.
Key words: cervical cancer, human papillomavirus, primary health care, screening, abnormal Pap smear
Cite This Article:
Please cite this article in press Fatimah Al-Mubarak et al., “The Correlation Between Human Papilloma Virus Infection And Abnormal Cervical Smears In Saudi Arabia”., Indo Am. J. P. Sci, 2021; 08(08).
Number of Downloads : 10
References:
[1] Alhamlan FS, Al-Qahtani AA, Al-Ahdal MN. Current studies on human papillomavirus in Saudi Arabia. J Infect Dev Ctries, 2015; 9:571-576.
[2] Palefsky J. 2018. UpToDate [ONLINE] Available at: https://www.uptodate.com/-contents-/human-papillomavirus-infections-epidemiology-and-disease-associa-tions?source=history_widget. [Accessed 08 November 2018].
[3] Al-Ahdal MN, Al-Arnous WK, Bohol MF, Abuzaid SM, Shoukri M, Elrady KS, Firdous N, Aliyan R, Taseer R, Al-Hazzani AA, Al-Qahtani AA. Human papillomaviruses in cervical specimens of women residing in Riyadh, Saudi Arabia: a hospital-based study. J Infect Dev Ctries, 2014; 8:320-325.
[4] Turki R, Sait K, Anfinan N, Sohrab SS, Abuzenadah AM. Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev, 2013;14:3177-3181.
[5] Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N. Role of cervical cancer biomarkers p16 and Ki67 in abnormal cervical cytological smear. J Obstet Gynaecol India, 2021; 71:72-77.
[6] Chen CC, Huang LW, Bai CH, Lee CC. Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis. Ann Saudi Med, 2016; 36:245-251.
[7] Yu L, Fei L, Liu X, Pi X, Wang L, Chen S. Application of p16/Ki-67 dual-staining cytology in cervical cancers. J Cancer, 2019; 10:2654-2660.
[8] Ordi J, Sagasta A, Munmany M, Rodríguez‐Carunchio L, Torné A, del Pino M. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy. Cancer Cytopathol, 2014; 122:227-235.
[9] McQuillan G, Kruszon-Moran D, Markowitz LE, Unger ER, Paulose-Ram R. 2017. Products – Data Briefs – Number 280. Prevalence of HPV in Adults Aged 18–69: United States, 2011–2014. [ONLINE] Available at: https://www.cdc.gov/nchs/-products/databriefs/db280.htm [Accessed 27 June 2021].
[10] Louie KS, De Sanjose S, Diaz M, Castellsague X, Herrero R, Meijer CJ, Shah K, Franceschi S, Muñoz N, Bosch FX. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer, 2009; 100:1191-1197.
[11] Green J, De Gonzalez AB, Smith JA, Franceschi S, Appleby P, Plummer M, Beral V. Human papillomavirus infection and use of oral contraceptives. Br J Cancer, 2003; 88:1713-1720.